IL157545A0 - Beta-carboline derivatives and their pharmaceutical use against depression and anxiety - Google Patents

Beta-carboline derivatives and their pharmaceutical use against depression and anxiety

Info

Publication number
IL157545A0
IL157545A0 IL15754502A IL15754502A IL157545A0 IL 157545 A0 IL157545 A0 IL 157545A0 IL 15754502 A IL15754502 A IL 15754502A IL 15754502 A IL15754502 A IL 15754502A IL 157545 A0 IL157545 A0 IL 157545A0
Authority
IL
Israel
Prior art keywords
anxiety
beta
pharmaceutical use
use against
carboline derivatives
Prior art date
Application number
IL15754502A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL157545A0 publication Critical patent/IL157545A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL15754502A 2001-04-03 2002-04-02 Beta-carboline derivatives and their pharmaceutical use against depression and anxiety IL157545A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0108337.7A GB0108337D0 (en) 2001-04-03 2001-04-03 Organic compounds
PCT/EP2002/003624 WO2002081471A1 (en) 2001-04-03 2002-04-02 Beta-carboline derivatives and its pharmaceutical use against depression and anxiety

Publications (1)

Publication Number Publication Date
IL157545A0 true IL157545A0 (en) 2004-03-28

Family

ID=9912165

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15754502A IL157545A0 (en) 2001-04-03 2002-04-02 Beta-carboline derivatives and their pharmaceutical use against depression and anxiety

Country Status (27)

Country Link
US (1) US6861430B2 (pt)
EP (1) EP1377578B1 (pt)
JP (1) JP4405732B2 (pt)
KR (1) KR100564840B1 (pt)
CN (1) CN1309721C (pt)
AR (1) AR035451A1 (pt)
AT (1) ATE517104T1 (pt)
AU (1) AU2002316828B2 (pt)
BR (1) BR0208566B1 (pt)
CA (1) CA2440014C (pt)
CZ (1) CZ295992B6 (pt)
EC (1) ECSP034754A (pt)
ES (1) ES2368389T3 (pt)
GB (1) GB0108337D0 (pt)
HU (1) HUP0400317A3 (pt)
IL (1) IL157545A0 (pt)
MX (1) MXPA03009057A (pt)
MY (1) MY134026A (pt)
NO (1) NO20034413L (pt)
NZ (1) NZ528370A (pt)
PE (1) PE20021018A1 (pt)
PL (1) PL210861B1 (pt)
PT (1) PT1377578E (pt)
RU (1) RU2003130644A (pt)
SK (1) SK12222003A3 (pt)
WO (1) WO2002081471A1 (pt)
ZA (1) ZA200306108B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
US7872133B2 (en) 2003-06-23 2011-01-18 Ono Pharmaceutical Co., Ltd. Tricyclic heterocycle compound
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
PT1829874E (pt) 2004-12-22 2014-04-10 Ono Pharmaceutical Co Composto tricíclico e sua utilização
US7879859B2 (en) * 2005-11-21 2011-02-01 Merck Sharp & Dohme Corp. Diagnosis and treatment of type 2 diabetes and other disorders
WO2007062175A2 (en) * 2005-11-21 2007-05-31 Amgen Inc. Spiro-substituted tricyclic heterocycles cxcr3 antagonists
EP2178537A4 (en) * 2007-07-19 2011-08-17 Merck Sharp & Dohme BETA-CARBOLIN DERIVATIVES AS ANTIDIBLE COMPOUNDS
WO2009016329A1 (en) * 2007-07-31 2009-02-05 Cambridge Enterprise Limited Use of gabaa receptor antagonists to treat cognitive impairment in patients with psychiatric conditions
WO2009155388A1 (en) 2008-06-20 2009-12-23 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
ES2541528T3 (es) 2008-11-19 2015-07-21 Forum Pharmaceuticals Inc. Tratamiento de trastornos cognitivos con (R)-7-cloro-N-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma
TW201028414A (en) 2009-01-16 2010-08-01 Merck Sharp & Dohme Oxadiazole beta carboline derivatives as antidiabetic compounds
CA2785790A1 (en) 2010-01-15 2011-07-21 Merck Sharp & Dohme Corp. Oxadiazole beta carboline derivatives as antidiabetic compounds
CN103221411B (zh) 2010-05-17 2016-05-11 富瑞姆制药公司 (R)-7-氯-N-(奎宁环-3-基)苯并[b]噻吩-2-甲酰胺盐酸盐单水合物的晶型
AU2013259871A1 (en) 2012-05-08 2014-11-20 Forum Pharmaceuticals Inc. Methods of maintaining, treating or improving cognitive function
CN111349096B (zh) * 2020-04-14 2021-03-09 石河子大学 一种吲哚类化合物及其制备方法、应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4118741A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
US6057340A (en) * 1998-02-03 2000-05-02 American Home Products Corporation Oxazole derivatives as serotonin-1A receptor agonists
NZ508765A (en) 1998-06-12 2003-10-31 Sod Conseils Rech Applic Beta-carboline derivatives and pharmaceuticals thereof that selectively bind somatostatin receptor subtypes

Also Published As

Publication number Publication date
JP4405732B2 (ja) 2010-01-27
CZ20032655A3 (cs) 2003-12-17
SK12222003A3 (sk) 2004-06-08
ES2368389T3 (es) 2011-11-16
HUP0400317A2 (hu) 2004-09-28
NZ528370A (en) 2005-10-28
KR100564840B1 (ko) 2006-03-28
WO2002081471A1 (en) 2002-10-17
ZA200306108B (en) 2004-07-05
ECSP034754A (es) 2003-10-28
US6861430B2 (en) 2005-03-01
BR0208566B1 (pt) 2013-12-24
EP1377578B1 (en) 2011-07-20
HUP0400317A3 (en) 2007-10-29
CA2440014A1 (en) 2002-10-17
CZ295992B6 (cs) 2005-12-14
JP2004525178A (ja) 2004-08-19
CA2440014C (en) 2010-11-23
BR0208566A (pt) 2004-03-30
PE20021018A1 (es) 2003-01-13
GB0108337D0 (en) 2001-05-23
US20040132735A1 (en) 2004-07-08
ATE517104T1 (de) 2011-08-15
NO20034413D0 (no) 2003-10-02
EP1377578A1 (en) 2004-01-07
MXPA03009057A (es) 2004-02-12
MY134026A (en) 2007-11-30
PL362571A1 (en) 2004-11-02
AU2002316828B2 (en) 2006-05-11
PT1377578E (pt) 2011-09-23
AR035451A1 (es) 2004-05-26
NO20034413L (no) 2003-10-02
RU2003130644A (ru) 2005-04-10
KR20040008150A (ko) 2004-01-28
PL210861B1 (pl) 2012-03-30
CN1500090A (zh) 2004-05-26
CN1309721C (zh) 2007-04-11

Similar Documents

Publication Publication Date Title
EP1367060A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE
EP1364957A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE
EP1364958A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF
HK1164133A1 (en) Nasal pharmaceutical formulations and methods of using the same
HUP0300746A3 (en) Proline derivatives and use thereof as drugs
PT1296974E (pt) Derivados 2-cianopirrolidina e sua utilização como medicamentos
HUP0401461A3 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU2001280188A1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
HK1091727A1 (en) Nasal pharmaceutical formulations and methods of using the same
AU2002354476A1 (en) Pyrazolopyridine derivatives and medicinal use thereof
IL157545A0 (en) Beta-carboline derivatives and their pharmaceutical use against depression and anxiety
GB0108470D0 (en) Pharmaceutical compositions and their use
TWI318974B (en) Acylaminothiazole derivatives, their preparation and their therapeutic use
PL367676A1 (en) Novel heterocyclic derivatives and medicinal use thereof
HK1064042A1 (en) Medicines and medicinal kits
IL153487A0 (en) Pharmaceutical compositions and methods for use
EP1379228A4 (en) (Z) -STYRYLBENZYLSULPONES AND THEIR PHARMACEUTICAL APPLICATIONS
IL153897A0 (en) Pharmaceutical compositions and methods for use
EP1407771A4 (en) SOPHORIDINE AND ITS USE AS ANALYZIC
AUPR916301A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AUPR606401A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
IL134240A0 (en) Inositol derivatives and their pharmaceutical use
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
HK1065792A1 (en) 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino Ä4,5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use